Screener
Cogent Biosciences, Inc. COGT Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
FAQ
- What is Cogent Biosciences, Inc.'s invested capital?
- Cogent Biosciences, Inc. (COGT) reported invested capital of $381.97M in Q1 2026.
- How has Cogent Biosciences, Inc.'s invested capital changed year-over-year?
- Cogent Biosciences, Inc.'s invested capital increased by 247.0% year-over-year, from $110.08M to $381.97M.
- What is the long-term trend for Cogent Biosciences, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s invested capital has grown at a 171.3% compound annual growth rate (CAGR), from -$2.32M to $340.26M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Cogent Biosciences, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude